大剂量地塞米松联合小剂量利妥昔单抗作为二线方案治疗65例原发免疫性血小板减少症患者的临床观察

OBJECTIVE: To observe the efficacy of high-dose dexamethasone in combination with low-dose rituximab as a second-line treatment for patients with immune thrombocytopenia (ITP). METHODS: 65 patients with ITP, previously by conventional dose of glucocorticoids, received high-dose dexamethasone in comb...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342512/
https://www.ncbi.nlm.nih.gov/pubmed/25854463
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342512/
https://www.ncbi.nlm.nih.gov/pubmed/25854463
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.03.007

Ejemplares similares